Cognitive Impairment Associated with Schizophrenia (CIAS) - Pipeline Review with Therapeutic Drugs Profile - H2 2017
Cognitive impairment associated with schizophrenia (CIAS) show various symptoms which have a very negative impact on the patients' quality of life and ability to function. The treatment of this disorder include antipsychotic medications that mark the need of the medicine as a must, and hence its therapeutic development is required to lead a normal life. To discuss in detail, Market Research Hub (MRH) has lately added a pipeline review titled as "Cognitive Impairment Associated with Schizophrenia (CIAS) - Pipeline Review,...
View full press release